106 related articles for article (PubMed ID: 31489122)
1. Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody
Booth L; Roberts JL; Poklepovic A; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Oncotarget; 2019 Aug; 10(49):5120-5122. PubMed ID: 31489122
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody
Booth L; Roberts JL; Poklepovic A; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Oncotarget; 2017 Oct; 8(52):90262-90277. PubMed ID: 29163826
[TBL] [Abstract][Full Text] [Related]
3. Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur
Nguyen T; Parker R; Hawkins E; Holkova B; Yazbeck V; Kolluri A; Kmieciak M; Rahmani M; Grant S
Oncotarget; 2019 Sep; 10(51):5383-5384. PubMed ID: 31523396
[TBL] [Abstract][Full Text] [Related]
4. Correction: Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?
Eyre TA
Oncotarget; 2019 Feb; 10(17):1661. PubMed ID: 30899436
[TBL] [Abstract][Full Text] [Related]
5. HDAC inhibitors enhance the immunotherapy response of melanoma cells.
Booth L; Roberts JL; Poklepovic A; Kirkwood J; Dent P
Oncotarget; 2017 Oct; 8(47):83155-83170. PubMed ID: 29137331
[TBL] [Abstract][Full Text] [Related]
6. Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity
Shi F; Zhang J; Liu H; Wu L; Jiang H; Wu Q; Liu T; Lou M; Wu H
Oncotarget; 2018 Mar; 9(24):17255. PubMed ID: 29683149
[TBL] [Abstract][Full Text] [Related]
7. Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix.
Mann M; Kumar S; Chauhan SS; Bhatla N; Kumar S; Bakhshi S; Gupta R; Sharma A; Kumar L
Oncotarget; 2019 Jul; 10(46):4802. PubMed ID: 31413820
[TBL] [Abstract][Full Text] [Related]
8. Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability.
Munari E; Zamboni G; Marconi M; Sommaggio M; Brunelli M; Martignoni G; Netto GJ; Moretta F; Mingari MC; Salgarello M; Terzi A; Picece V; Pomari C; Lunardi G; Cavazza A; Rossi G; Moretta L; Bogina G
Oncotarget; 2018 Dec; 9(97):37077. PubMed ID: 30651938
[TBL] [Abstract][Full Text] [Related]
9. Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy.
Bucher F; Friedlander M; Yea K
Oncotarget; 2018 Sep; 9(69):33244. PubMed ID: 30237865
[TBL] [Abstract][Full Text] [Related]
10. Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II.
Mazumder S; Swank V; Komar AA; Johnson JM; Tuohy VK
Oncotarget; 2022; 13():905-906. PubMed ID: 35937501
[TBL] [Abstract][Full Text] [Related]
11. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
12. Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC).
Goldenberg DM; Cardillo TM; Govindan SV; Rossi EA; Sharkey RM
Oncotarget; 2020 Mar; 11(10):942. PubMed ID: 32206190
[TBL] [Abstract][Full Text] [Related]
13. Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K
Oncotarget; 2018 Aug; 9(64):32403. PubMed ID: 30190798
[TBL] [Abstract][Full Text] [Related]
14. Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
Ilie M; Khambata-Ford S; Copie-Bergman C; Huang L; Juco J; Hofman V; Hofman P
PLoS One; 2017; 12(10):e0186537. PubMed ID: 29028832
[TBL] [Abstract][Full Text] [Related]
15. Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.
Gravina GL; Mancini A; Colapietro A; Marampon F; Sferra R; Pompili S; Biordi LA; Iorio R; Flati V; Argueta C; Landesman Y; Kauffman M; Shacham S; Festuccia C
Oncotarget; 2019 Oct; 10(59):6393-6395. PubMed ID: 31695847
[TBL] [Abstract][Full Text] [Related]
16. Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
Hanson K; Robinson SD; Al-Yousuf K; Hendry AE; Sexton DW; Sherwood V; Wheeler GN
Oncotarget; 2018 Nov; 9(93):36645. PubMed ID: 30564304
[TBL] [Abstract][Full Text] [Related]
17. Correction: Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia.
Lee HJ; Lee J; Jeong P; Choi J; Baek J; Ahn SL; Moon Y; Heo JD; Choi YH; Chin YW; Kim YC; Han SY
Oncotarget; 2018 Apr; 9(28):20219. PubMed ID: 29733074
[TBL] [Abstract][Full Text] [Related]
18. Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Caroline R; Sofia G; Catherine P; Remi B; Pierre C; Olivier B; Laurent G; Valentin A; Claude C; Odile F
Oncotarget; 2019 Mar; 10(22):2236. PubMed ID: 31040915
[TBL] [Abstract][Full Text] [Related]
19. HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.
Woods DM; Sodré AL; Villagra A; Sarnaik A; Sotomayor EM; Weber J
Cancer Immunol Res; 2015 Dec; 3(12):1375-85. PubMed ID: 26297712
[TBL] [Abstract][Full Text] [Related]
20. Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
Oncotarget; 2019 Feb; 10(16):1602. PubMed ID: 30899428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
